Our findings suggest that obesity modulates the metabolic gene expression profile of ERRα, a potent modulator of cellular metabolism, in breast cancer patients, in a manner consistent with the high cholesterol-induced alterations in ERRα-dependent metabolic activity in vitro in breast cancer cells. This evidence concerns the gene ESRRA and obesity due to melanocortin 4 receptor deficiency.